counterfeit medicines
21 articles related to "counterfeit medicines"
-
EU Parliament Rejects ACTA; Allowing for Continued Access to Generic Medicines in Developing Countries
Brussels/Geneva, 4 July 2012 - Members of the European Parliament today voted to reject the Anti-Counterfeiting Trade Agreement (ACTA) put before them by the European Commission. International medical...
Press Release – Last updated 04 July 2012
msfaccess.org/about-us/media-room/press-releases/eu-parliament-rejects-acta-allowing-continued-access-generic -
Joint statement by MSF, HAI Africa & KELIN on the Kenya Anti-Counterfeit Act 2008 decision
Health activists welcome High Court judgment on anti-counterfeit law 20 April 2012 -- After three years of waiting, health activists today welcomed a decision by the High court that the...
Statements, Speeches, Letters – Last updated 20 April 2012
msfaccess.org/content/joint-statement-msf-hai-africa-kelin-kenya-anti-counterfeit-act-2008-decision -
HAI Europe, Oxfam, MSF & the TACD call on EU parliamentarians to condemn ACTA independently of the ECJ referral
On February 22, the European Commission announced its intent to ask the European Court of Justice (ECJ) for an opinion on the conformity of the Anti-Counterfeiting Trade Agreement with fundamental...
Statements, Speeches, Letters – Last updated 26 March 2012
msfaccess.org/content/hai-europe-oxfam-msf-tacd-call-eu-parliamentarians-condemn-acta-independently-ecj-referral -
The reality behind the rhetoric: How European policies risk harming access to generic medicines in developing countries
The availability of affordable generic medicines has been critical to expanding access to treatment for HIV / AIDS and other diseases in developing countries. In recent years, access to generics...
In Medical Journals / Research Articles – Last updated 14 January 2011
msfaccess.org/content/reality-behind-rhetoric-how-european-policies-risk-harming-access-generic-medicines -
MSF HIV/AIDS in Kenya: majority of patients with suspect Zidolam-N receive follow-up consultations
MSF has followed-up nearly 3,000 of the HIV/AIDS patients who received antiretroviral drugs (ARVs) from falsified batches and provided them with replacement ARVs. MSF is working hard to get in contact...
Statements, Speeches, Letters – Last updated 29 November 2011
msfaccess.org/content/msf-hivaids-kenya-majority-patients-suspect-zidolam-n-receive-follow-consultations -
Falsified Medicines Enter Supply Chain in Kenya
MSF is taking all measures to ensure adequate treatment and medical follow up for patients Nairobi, 30 September 2011 -- On 5th and 7th September, Médecins Sans Frontières (MSF) missions...
Press Release – Last updated 03 October 2011
msfaccess.org/about-us/media-room/press-releases/falsified-medicines-enter-supply-chain-kenya -
Beat the Bulldozers: Separating fake from life-saving generic medicines
Multimedia – Last updated 11 August 2011
msfaccess.org/content/beat-bulldozers-separating-fake-life-saving-generic-medicines -
Briefing Note: Time to Focus on Quality
Médecins Sans Frontières briefing note ahead of the February 2011 meeting of Working Group of WHO Member States on substandard/ spurious/ falsely-labelled/ falsified/ counterfeit medical...
Briefing – Last updated 01 February 2011
msfaccess.org/content/briefing-note-time-focus-quality -
'Counterfeit' confusion diverts action from drug quality
Both fake and substandard medicines threaten public health, and efforts to tackle them must put the focus on quality, says Leena Menghaney. Numerous policy initiatives claim to promote patient...
Web article – Last updated 04 April 2011
msfaccess.org/content/counterfeit-confusion-diverts-action-drug-quality -
10 Stories that Mattered to Access to Medicines in 2010
Through its Campaign for Access to Essential Medicines, Médecins Sans Frontières (MSF) has been closely following the developments in the world of access to medicines, vaccines and diagnostics. SUMMARY Among...
Report – Last updated 04 January 2011
msfaccess.org/content/10-stories-mattered-access-medicines-2010
↑ To top


